|
Market Cap (17-May) $8,414,961,152 (204th) |
Close (30-Jun) $11.22 |
Volume (30-Jun) 664,557 |
Shortsold (5-May) 16,072,273 (4.76%) (53rd) |
|
52w High $31.97 |
52w Low $14.42 |
P/E 57.80 |
EPS 0.15 |
TLX released this announcement to the ASX on 25 October 2022, 10:45. The announcement is not marked as price sensitive, and is 5 page(s) in length and 24.16kb in size.
You can view all announcements from TLX and see how they appear on a price chart on the announcements page.
At the date of this announcement, TLX was 2.864% short sold according to ASIC data. It was ranked the 104th most shorted stock on the ASX. It is now ranked as the 53rd most shorted stock on the ASX with 4.757% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from TLX | |
|---|---|
| Cleansing Notice | 28 June 2023, 8:23 |
| Application for quotation of securities - TLX | 28 June 2023, 8:23 |
| Proposed issue of securities - TLX | 21 June 2023, 18:12 |
| Notification of cessation of securities - TLX | 25 October 2022, 10:45 |
| Q3 2022 Business Update to accompany quarterly results | 20 October 2022, 9:01 |
| Appendix 4C and Activities Report - September 2022 Quarter | 20 October 2022, 8:45 |
| TLX250-CDx Indication Expansion - Preliminary Data | 18 October 2022, 8:49 |
You must be logged in to post a reply.
Telix Pharmaceuticals 